Delivery Order SPE2DB22D3501-SPE2DB24FUN92
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $6,015.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a specialty pharmaceutical product, with a period of performance through March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $9,550.17 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This contract is for the supply of RINVOQ ER 15 MG TABLET, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,492.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. The contract has a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract valued at $27,159.67. This contract is to provide RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with a performance period through March 6, 2024. Amerisourcebergen Drug Corp is an established prime contractor for DLA, holding an indefinite delivery contract valued up to $999,999,999.00 through December 31, 2025...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $7,463.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Rinvoq ER 15 mg tablet. This delivery order contract supports DLA Troop Support Medical in supplying pharmaceuticals and medical supplies to military treatment programs and facilities. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,084.60 contract is for the delivery of RINVOQ ER 15 MG TABLET, a specialty pharmaceutical product, with a performance period through April 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $26,163.08 firm-fixed-price delivery order contract to Amerisource Bergen Drug Corporation's Corporate Office division. The contract is for the supply of RINVOQ ER 30 MG TABLET, a pharmaceutical product, with a period of performance through September 13, 2024. This contract award is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA Troop Support Medical and Amerisource Bergen,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $6,863.94 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 45 MG TABLET UU 28S. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $6,015.42 firm fixed price delivery order is for the supply of a pharmaceutical product, RINVOQ ER 30 MG TABLET, with an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $3,229.97 to provide the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. This delivery order has a completion date of February 8, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUN92Delivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a wholly owned subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $8,452.49 order is for the supply of a specialty pharmaceutical product, RINVOQ ER 15 MG Tablet, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs worldwide. The contract does not have any set-aside designations. Amerisourcebergen Drug Corp has a strong track record of successfully delivering pharmaceuticals, medical materials, and related distribution services to DLA and other government agencies such as the Department of Justice.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 2/12/24 |